To advance Northeastern’s standing as a go-to institution for academic researchers interested in drug discovery is the vision of Dr. Diomedes Logothetis, the new chair of the Department of Pharmaceutical Sciences.
New research led by Northeastern University suggests that Alzheimer’s disease may not progress like falling dominoes, as conventional wisdom holds, with one molecular event sparking the formation of plaques throughout the brain.
Kenneth Henderson can point precisely to the moment when his career spun in an exciting new direction: a five-month industry placement at Merck in London.
A team led by University Distinguished Professor of Biology Kim Lewis received a five-year, $9 million grant from the National Institute of Health’s National Institute of Allergy and Infectious Diseases to launch a novel platform for developing antibiotics that kill pathogens without encountering resistance.
Dr. Jared Auclair comes to the position having been a significant contributor to the university’s educational mission teaching Protein Mass Spectrometry and establishing and operating Northeastern’s Biopharmaceutical Analysis Training Laboratory in Burlington, MA
Now in its thirteenth year, Northeastern’s biotechnology program incorporates key concepts in business with a solid science curriculum.
Drs. Slava Epstein and Kim Lewis’s journey towards the ultimate cure is described in The New Yorker Annals of Science, June 20, 2016.
Kenneth W. Henderson, a scholar of synthetic and structural inorganic chemistry, is a professor and chair of the Department of Chemistry and Biochemistry at the University of Notre Dame. He will join Northeastern on July 1.
Metastasis is the cause of approximately 90 percent of deaths among cancer patients. How does metastasis come about? And can we stop it? Research published by Dr. Ashagiri and his team in Biophysical Journal reveals how the abnormal protein-fiber scaffolding of tumors and the agility of the cancer cells themselves come together in a perfect storm to […]
At Northeastern’s Antimicrobial Discovery Center, research on how the bacterium that causes Lyme disease evades antibiotics is conducted by Dr. Kim Lewis and his team.